morphine, naltrexone combination: Clinical Trials

6 trials of morphine, naltrexone combination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 terminated. 2 Phase 1, 2 Phase 3, 2 Phase 4, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 32Completed 2
Phase 42Terminated 2
Phase 21Completed 1

Follow morphine, naltrexone combination: new trials by email Literature Review of morphine, naltrexone combination trials Research Report on morphine, naltrexone combination

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users
Placebo, MS Contin (morphine sulfate, controlled release), EMBEDA (morphine sulfate / naltrexone hydrochloride) - Nondependent Opioid Abuse, Episodic
Phase 1CompletedPfizer802011-02-012012-05-31
Conversion to Embeda With Rescue Trial
morphine sulfate and naltrexone hydrochloride (EMBEDA) - Chronic Disease, Pain
Phase 4TerminatedPfizer6842010-08-012012-10-11
Safety Study to Assess Opiate Withdrawal Signs and Symptoms in Opioid Dependent Patients
EMBEDA™ (morphine sulfate/naltrexone hydrochloride) crush, EMBEDA™ (morphine sulfate/naltrexone hydrochloride) whole - Chronic Pain
Phase 4TerminatedPfizer142010-04-012012-07-13
Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)
ALO-01, MSIR, Placebo - Healthy
Phase 1 / Phase 2CompletedPfizer322007-03-012013-09-16
A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee
ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release), Placebo - Osteoarthritis, Chronic Pain
Phase 3CompletedPfizer5472006-12-012013-09-20
Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain
ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER) - Pain
Phase 3CompletedPfizer4672006-12-012013-09-20

Conditions studied

Chronic Pain (4)  ·  Pain (3)  ·  Arthralgia (1)  ·  Back Pain (1)  ·  Chronic Disease (1)  ·  Neuralgia, Postherpetic (1)  ·  Osteoarthritis (1)  ·  Pressure Ulcer (1)  ·  Recurrence (1)  ·  Substance Withdrawal Syndrome (1)

Sponsors

Pfizer (6)

Countries

United States (5)  ·  Canada (1)

Top investigators

James B. Jones, MD, PharmD (2)  ·  Myroslav Romach, MSC, MD (1)

Results publications

PMID 26695349, PMID 21075272, PMID 21904098, PMID 23709323, PMID 23745947, PMID 26185466, PMID 27782769